Lorcainide
From Self-sufficiency
File:Lorcainide.svg | |
Systematic (IUPAC) name | |
---|---|
N-(4-chlorophenyl)-N-(1-isopropylpiperidin-4-yl)-2-phenylacetamide | |
Pharmacokinetic data | |
Protein binding | 78 |
Biological half-life | 14.3 +/-3.7 |
Identifiers | |
CAS Number | 59729-31-6 |
ATC code | C01BC07 (WHO) |
PubChem | CID 42884 |
Chemical data | |
Formula | C22H27ClN2O |
Molar mass | 370.915 g/mol[[Script error: No such module "String".]] |
Lorcainide is a class 1c antiarrhythmic agent. It was discovered at Janssen Pharmaceutica in 1968.
References
- Kesteloot H, Stroobandt R., Clinical experience with lorcainide (R 15 889), a new anti-arrhythmic drug, Arch Int Pharmacodyn Ther. 1977 Dec;230(2):225-34.
- Carmeliet E, Janssen PA, Marsboom R, Van Nueten JM, Xhonneux R., Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide, Arch Int Pharmacodyn Ther. 1978 Jan;231(1):104-30.
30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Antiarrhythmic agents
- Piperidines
- Sodium channel blockers
- Organochlorides
- Anilides
- Acetamides
- Cardiovascular system drug stubs